Speaker illustration

Professor Peter S Sever

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

Hypertension management in the very old: less is more?

Event: ESC CONGRESS 2019

Topic: Cardiovascular Nursing and Allied Professions

Session: Advancing the management of hypertension for nurses and allied professions

Thumbnail

Benefit of LDL-C lowering with evolocumab on cardiovascular outcomes by age & sex: an analysis of the FOURIER trial

Event: ESC Congress 2018

Topic: Lipid-Lowering Agents

Session: PCSK9 inhibitors - For the many or the few?

Thumbnail

Challenging the data.

Event: ESC CONGRESS 2017

Topic: Endothelial function

Session: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in CVD prevention

Thumbnail

Future perspectives in lipid lowering and CVD prevention.

Event: ESC CONGRESS 2017

Topic: Atherosclerosis

Session: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in cardiovascular disease prevention

Thumbnail

PCSK9 inhibition & CV events: review of recent and upcoming hard endpoint outcome trials.

Event: ESC CONGRESS 2017

Topic: Lipids (Epidemiology and Prevention)

Session: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition & cardiovascular outcomes: review of lipid targets and treatment strategies (EBAC Accredited)

Thumbnail

This platform is supported by

logo Novo Nordisk